Product Information
IMURAN 50 MG TABLET is a brand product labeled by Sebela Pharmaceuticals Inc., priced at $8.8907 per EA under NDC 54766059010. Its NADAC has been published 78 times since Oct 23, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Sebela Pharmaceuticals Inc.NDC
54766059010
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
4/4/2025
Active Ingredients
AZATHIOPRINEApproval Type
New Drug (NDA)
FDA Application
NDA016324FDA Approved
Before 1982
TE Code
AB
On Market Since
12/1/2017
Pharmacological Classes
Price Statistics
The NADAC for IMURAN 50 MG TABLET has been published 78 times since Oct 23, 2024, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8907 per EA |
|---|---|
| All-time high | $8.8907 (Apr 15, 2026) |
| All-time low | $8.4666 (Feb 19, 2025) |
| 52-week high | $8.8907 |
| 52-week low | $8.8907 |
| Median price | $8.8907 |
| Average price | $8.7641 |
| Largest weekly change | +5.0% (Apr 9, 2025) |
| Weeks tracked | 78 |
| Tracking since | Oct 23, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+4.7%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the azathioprine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sebela Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
azathioprine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Purine Antimetabolite class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IMURAN 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMURAN 50 MG TABLET, manufactured by Sebela Pharmaceuticals Inc., is $8.8907 per EA (NDC 54766059010), effective Apr 15, 2026.
How has the price of IMURAN 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMURAN 50 MG TABLET has risen 4.7%. It has been tracked across 78 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for IMURAN 50 MG TABLET?
Since Oct 23, 2024, the NADAC for IMURAN 50 MG TABLET has ranged from a low of $8.4666 (Feb 19, 2025) to a high of $8.8907 (Apr 15, 2026), with a median of $8.8907 per EA.
Are there cheaper alternatives to IMURAN 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of IMURAN 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures IMURAN 50 MG TABLET?
IMURAN 50 MG TABLET (NDC 54766059010) is labeled by Sebela Pharmaceuticals Inc., and CMS classifies it as a brand product.